MannKind Corp
MNKD
#5811
Rank
$1.25 B
Marketcap
$3.90
Share price
3.72%
Change (1 day)
-28.04%
Change (1 year)

EPS for MannKind Corp (MNKD)

EPS in 2023 (TTM): -$0.19

According to MannKind Corp's latest financial reports the company's current EPS (TTM) is -$0.13. In 2022 the company made an earnings per share (EPS) of -$0.34 a decrease over its 2021 EPS that were of -$0.32.

EPS history for MannKind Corp from 2004 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$0.19-44.12%
2022-$0.346.25%
2021-$0.3228%
2020-$0.25-7.41%
2019-$0.27-55.74%
2018-$0.61-45.05%
2017-$1.11-188.1%
2016$1.26-128.31%
2015-$4.4574.51%
2014-$2.55-20.31%
2013-$3.20-32.63%
2012-$4.75-28.03%
2011-$6.60-12%
2010-$7.50-27.54%
2009-$10.35-30.3%
2008-$14.85-18.85%
2007-$18.30-19.03%
2006-$22.6056.94%
2005-$14.40-21.74%
2004-$18.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
$0.76-684.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
$4.08-3,236.63%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Eli Lilly
LLY
$30.87-23,843.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
$0.99-863.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Halozyme Therapeutics
HALO
$3.52-2,807.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-$2.96 2,176.92%๐Ÿ‡บ๐Ÿ‡ธ USA